Recent Controversies in Initiation of Drug Therapy for Pulmonary Arterial Hypertension

被引：0
|
作者：
Lau, Edmund M. [1 ,2 ]
机构：
[1] Univ Sydney, Fac Med, Sydney, NSW, Australia
[2] Royal Prince Alfred Hosp, Sydney, NSW, Australia
来源：
JOURNAL OF CARDIAC FAILURE | 2022年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
026
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
  • [1] Drug therapy: Treatment of pulmonary arterial hypertension
    Humbert, M
    Sitbon, O
    Simonneau, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (14): : 1425 - 1436
  • [2] WORSENING HYPOXIA AFTER THERAPY INITIATION IN PULMONARY ARTERIAL HYPERTENSION
    Bhattacharya, Sanjeeb
    Caccamo, Marco
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 2367 - 2367
  • [3] Drug-induced pulmonary arterial hypertension: a recent outbreak
    Montani, David
    Seferian, Andrei
    Savale, Laurent
    Simonneau, Gerald
    Humbert, Marc
    [J]. EUROPEAN RESPIRATORY REVIEW, 2013, 22 (129): : 244 - 250
  • [4] Drug Interactions Associated With Pulmonary Arterial Hypertension Therapy
    Au, Trang H.
    Fagan, Nancy L.
    Schuller, Dan
    Malesker, Mark A.
    [J]. US PHARMACIST, 2013, 38 (10) : HS21 - HS24
  • [5] Prognostic relevance of pulmonary arterial compliance after therapy initiation or escalation in patients with pulmonary arterial hypertension
    Ghio, Stefano
    D'Alto, Michele
    Badagliacca, Roberto
    Vitulo, Patrizio
    Argiento, Paola
    Mule, Massimiliano
    Tuzzolino, Fabio
    Scelsi, Laura
    Romeo, Emanuele
    Raineri, Claudia
    Martino, Lavinia
    Tamburino, Corrado
    Poscia, Roberto
    Vizza, Carmine Dario
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 230 : 53 - 58
  • [6] Prognostic relevance of pulmonary arterial compliance after therapy initiation or escalation in patients with pulmonary arterial hypertension
    Ghio, S.
    Badagliacca, R.
    D'Alto, M.
    Vitulo, P.
    Argiento, P.
    Mule, M.
    Tuzzolino, F.
    Scelsi, L.
    Romeo, E.
    Raineri, C.
    Martino, L.
    Tamburino, C.
    Poscia, R.
    Greco, A.
    Vizza, C. D.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 156 - 156
  • [7] The impact of drug-drug interactions on pulmonary arterial hypertension therapy
    Ciraci, Rocco
    Tirone, Giampaolo
    Scaglione, Francesco
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2014, 28 (01) : 1 - 8
  • [8] Current drug targets and future therapy of pulmonary arterial hypertension
    Ito, Takayuki
    Ozawa, Keiya
    Shimada, Kazuyuki
    [J]. CURRENT MEDICINAL CHEMISTRY, 2007, 14 (06) : 719 - 733
  • [9] Longitudinal Effects of Initiation of Parenteral Prostanoid Therapy for the Treatment of Pulmonary Arterial Hypertension, The Pulmonary Hypertension Association Registry
    Pan, H.
    Argula, R. G.
    Badesch, D. B.
    De Marco, T.
    Elwing, J. M.
    Grinnan, D.
    Lammi, M. R.
    Mazimba, S.
    Raval, A. A.
    Ryan, J. J.
    Shlobin, O. A.
    Thenappan, T.
    Mathai, S. C.
    Leary, P. J.
    Al-Naamani, N.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [10] Severely worsening dyspnea after initiation of macitentan therapy for pulmonary arterial hypertension
    Maeder, Micha T.
    Kleiner, Rebekka
    Weilenmann, Daniel
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 202 : 244 - 245
12345